Government-backed autoinjector specialist AktiVax shutters ‘substantially all of its operations,’ lays off 70 fkansteiner Tue, 09/05/2023 – 15:48 More: Government-backed autoinjector specialist AktiVax shutters 'substantially all of its operations,' lays off 70 Source: fierce
read moreCSL Vifor lays off 85 staffers in US commercial group in wake of $11.7B buyout zbecker Tue, 09/05/2023 – 15:44 More: CSL Vifor lays off 85 staffers in US commercial group in wake of .7B buyout Source: fierce
read moreFierce 50 spotlight: Breakthroughs category chair Eric Sagonowsky aellison Tue, 09/05/2023 – 11:19 More: Fierce 50 spotlight: Breakthroughs category chair Eric Sagonowsky Source: fierce
read moreSeagen, Genmab’s Tivdak improves survival for cervical cancer patients in phase 3 trial zbecker Tue, 09/05/2023 – 10:40 More: Seagen, Genmab's Tivdak improves survival for cervical cancer patients in phase 3 trial Source: fierce
read moreYears after $2B buyout, Nestlé ditches Aimmune’s peanut allergy drug Palforzia aliu Tue, 09/05/2023 – 10:22 More: Years after B buyout, Nestlé ditches Aimmune's peanut allergy drug Palforzia Source: fierce
read moreCandidate ESO-101 will treat participating patients across five European countries More: EsoCap finalises recruitment for eosinophilic esophagitis study Source: News
read more© 1994 - 2023 B.M. Pharmaceuticals